Archives

by in
Entry Author Date Location
Merck and Roche Back Adimab, Viral Contamination Closes Genzyme Plant, Interlace Ties on $20.5M, & More Boston-Area Life Sciences News 06/17/09 Boston
New Owner Laying Off a Quarter of Indevus Pharma Employees 06/10/09 Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter 03/17/09 Boston
Deux Deals for Dyax, Au Revoir for Vertex’s Boger, Grande Alliance for Idenix and GSK, & More Boston-Area Life Sciences News 02/11/09 Boston
Indevus: Mixed Results with HIV Blocker 02/09/09 Boston
Archemix Partners with GSK, EMC Acquires SourceLabs Assets, Satori Raises $22M to Take on Alzheimer’s, & More Boston-Area Deals News 01/09/09 Boston
Forma Emerges With Well-Formed Cancer-Drug Strategy, Biogen Idec Preps for Parkinson’s Drug Data, Endo Buys out Indevus, & More Boston-Area Life Sciences News 01/07/09 Boston
Indevus, Maker of ‘Male Menopause’ Drug, Agrees to $370M Takeover by Endo 01/05/09 Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter 11/25/08 Boston
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News 10/01/08 Boston
Indevus Puts New Acromegaly Treatment Head-to-Head with Novartis Treatment in Phase 3 Trial 09/30/08 Boston
Investors Radio in $32M for Vanu, JumpTap’s Bank Balance Hops up by $26M, Quanterix Pinpoints $15M, & More Deals News 09/02/08 Boston
Proteostasis Therapeutics Procures $45M, Stealthy Startup Gets Serious About Shampoo, MA Life Sciences Center Chief Shares Her Plans, & More Life Sciences News 08/27/08 Boston
Indevus Pharma Raises $105M in Debt Sale 08/26/08 Boston
Vertex Cashes Out HIV Drugs, FDA Smiles on Infinity and Frowns on Indevus, Alnylam Makes Cross-Border Investment, & More Life Sciences News 06/05/08 Boston
Indevus Drug Delayed by FDA Safety Questions, Shares Plummet 06/04/08 Boston
Page 1 of 1